The A∙WOL Consortium consists of key expert onchocerciasis/filariasis laboratories based in the UK (Liverpool and London), Germany (Bonn), Africa (Ghana) and the USA:
In addition to these, the Consortium also includes collaborating pharmaceutical companies with technology platforms for high throughput screening (HTS) of drug combinations. Our group includes the recognised international experts in their fields, who collectively are capable of carrying out almost the entire drug discovery and development process, which is required for new drugs to treat human filarial diseases.
........................................
United Kingdom
Liverpool
Liverpool School of Tropical Medicine
Taylor Lab
Ward Lab
London
Northwick Park Institute for Medical Research
Townson Lab
........................................
Europe
Germany
University Clinic Bonn
Hoerauf Lab
........................................
Africa
Ghana
KCCR Ghana
Adjei Lab
........................................
USA
Athens, GA
TRS Labs Inc
McCall Lab
Ipswich, MA
New England Biolabs (NEB)
Slatko Lab
Carlow Lab
Kumar Lab
........................................
Asia
Singapore